The University of Iowa

State Hygienic Laboratory

Breadcrumb

  1. Home
  2. Testing Specialties
  3. Diagnostic and Clinical Testing

Test Detail


Rabies Virus - Human Specimen

Back to Test Directory
Test Description
  • Contact: Reference Microbiology (319) 335-4335
  • Test Request Form: CDC Submission Form. Call the lab at 319/335-4335 for form and instructions.
  • SHL OpenELIS Code:
Diagnosis of human rabies infection.
Panel Components
Multiple tests are necessary to diagnose rabies ante-mortem in humans.
Performed Method
Centers for Disease Control and Prevention
Variable methodologies.
Fee
No charge
Specimen Requirements
Specimen Type: Recommended sample type from CDC
Collection Instructions: Specimen type and containment is based on the test method(s) recommended by the CDC.
Shipping:
Contact the lab before sending a specimen. A completed CDC Specimen submission form (CDC 50.34 Human) must be submitted along with the specimen(s).
Temperature and Stability: Temperature will be based on the recommended test
Expected Results:
Negative, Positive, Indeterminate
Comments
Consultation with a local or state health official following a potential exposure can help determine the best course of action based on current public health recommendations. Several tests are necessary to diagnose rabies ante-mortem (before death) in humans; no single test is sufficient. Tests are performed on samples of saliva, serum, spinal fluid, and skin biopsies of hair follicles at the nape of the neck. Saliva can be tested by virus isolation or reverse transcription followed by polymerase chain reaction (RT-PCR). Serum and spinal fluid are tested for antibodies to rabies virus. Skin biopsy specimens are examined for rabies antigen in the cutaneous nerves at the base of hair follicles.
The University of Iowa

State Hygienic Laboratory

General inquires
SHL Client Services
319-335-4500 or 1-800-421-IOWA (4692)
ask-shl@uiowa.edu

Footer primary

  • HIPAA Notice of Privacy Practice
  • Copyright 2025 The University of Iowa
  • Privacy Notice
  • UI Nondiscrimination Statement
  • Accessibility